Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05769_nanopub.RAV1A7u-hJs3TbTSj-wJjV5y7WQvGhnyrSOnkG6e0p8o0#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05769 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05769 label "LCP-AtorFen [drugbank:DB05769]" assertion.
- drugbank:DB05769 seeAlso DB05769 assertion.
- drugbank:DB05769 description "LCP-AtorFen is a fixed-dose combination therapy for the treatment of high cholesterol levels combining atorvastatin (the active ingredient of Lipitor®) and the lowest dose of fenofibrate without food effect. LCP-AtorFen is designed to be a once daily tablet offering a powerful and safe treatment of high cholesterol levels, addressing three primary cardiovascular risk factors: low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) and triglycerides (TG)." assertion.
- drugbank:DB05769 identifier "drugbank:DB05769" assertion.
- drugbank:DB05769 title "LCP-AtorFen" assertion.
- drugbank:DB05769 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05769 drugbank_vocabulary:drugbank-id "DB05769" assertion.
- drugbank:DB05769 bio2rdf_vocabulary:x-identifiers.org DB05769 assertion.
- drugbank:DB05769 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05769" assertion.
- drugbank:DB05769 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05769 bio2rdf_vocabulary:identifier "DB05769" assertion.